VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 15 filers reported holding VERONA PHARMA PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,180,238 | -22.9% | 1,115,352 | 0.0% | 7.49% | -35.1% |
| Q2 2023 | $23,578,541 | +5.3% | 1,115,352 | 0.0% | 11.55% | +7.2% |
| Q1 2023 | $22,396,268 | -35.7% | 1,115,352 | -16.3% | 10.78% | -53.1% |
| Q4 2022 | $34,817,833 | +155.7% | 1,332,485 | 0.0% | 22.99% | +154.2% |
| Q3 2022 | $13,618,000 | +143.9% | 1,332,485 | 0.0% | 9.04% | +127.0% |
| Q2 2022 | $5,583,000 | -16.0% | 1,332,485 | 0.0% | 3.98% | +11.0% |
| Q1 2022 | $6,649,000 | -25.7% | 1,332,485 | 0.0% | 3.59% | +13.6% |
| Q4 2021 | $8,954,000 | +22.6% | 1,332,485 | 0.0% | 3.16% | +117.0% |
| Q3 2021 | $7,302,000 | -16.2% | 1,332,485 | 0.0% | 1.46% | +4.4% |
| Q2 2021 | $8,714,000 | -21.8% | 1,332,485 | 0.0% | 1.40% | -30.4% |
| Q1 2021 | $11,140,000 | +19.4% | 1,332,485 | 0.0% | 2.00% | +25.2% |
| Q4 2020 | $9,327,000 | +12.2% | 1,332,485 | 0.0% | 1.60% | -39.7% |
| Q3 2020 | $8,315,000 | +301.3% | 1,332,485 | +200.4% | 2.66% | +235.8% |
| Q2 2020 | $2,072,000 | +13.3% | 443,596 | 0.0% | 0.79% | -0.6% |
| Q1 2020 | $1,828,000 | -28.3% | 443,596 | 0.0% | 0.80% | -18.5% |
| Q4 2019 | $2,551,000 | +25.9% | 443,596 | 0.0% | 0.98% | -7.6% |
| Q3 2019 | $2,027,000 | -10.4% | 443,596 | 0.0% | 1.06% | +9.4% |
| Q2 2019 | $2,262,000 | -21.5% | 443,596 | 0.0% | 0.97% | -56.0% |
| Q1 2019 | $2,883,000 | -32.7% | 443,596 | 0.0% | 2.20% | -51.3% |
| Q4 2018 | $4,281,000 | – | 443,596 | – | 4.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |